Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
about
Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.The present state of antineoplaston research (1).Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
P2860
Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phase II study of antineoplast ...... glioma: a preliminary report.
@ast
Phase II study of antineoplast ...... glioma: a preliminary report.
@en
Phase II study of antineoplast ...... glioma: a preliminary report.
@nl
type
label
Phase II study of antineoplast ...... glioma: a preliminary report.
@ast
Phase II study of antineoplast ...... glioma: a preliminary report.
@en
Phase II study of antineoplast ...... glioma: a preliminary report.
@nl
prefLabel
Phase II study of antineoplast ...... glioma: a preliminary report.
@ast
Phase II study of antineoplast ...... glioma: a preliminary report.
@en
Phase II study of antineoplast ...... glioma: a preliminary report.
@nl
P2093
P1433
P1476
Phase II study of antineoplast ...... glioma: a preliminary report.
@en
P2093
Barbara G Szymkowski
Gabor F Jurida
Jaroslaw K Paszkowiak
Mark Bestak
Maxwell L Axler
Mohammad I Khan
Robert A Weaver
Robert I Lewy
Stanislaw R Burzynski
Tomasz J Janicki
P304
P356
10.2165/00126839-200304020-00002
P577
2003-01-01T00:00:00Z